Jeffery Kelly
Founder bij Protego Biopharma, Inc.
Profiel
Jeffery W.
Kelly is the founder of FoldRx.
Pharmaceuticals LLC (founded in 2003), Proteostasis Therapeutics, Inc. (founded in 2006), Protego Biopharma, Inc. (founded in 2017), and Yumanity Therapeutics, Inc. (founded in 2006).
He is currently a Director at The Scripps Research Institute (since 2000), Yumanity, Inc., and The George E Hewitt Foundation For Medical Research.
He has also held the position of Director at Yumanity Holdings LLC.
Dr. Kelly's education includes a doctorate degree from The University of North Carolina at Asheville (conferred in 1986).
Actieve functies van Jeffery Kelly
| Bedrijven | Functie | Begin |
|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Director/Board Member | 01-01-2019 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Director/Board Member | - |
| The George E Hewitt Foundation For Medical Research | Director/Board Member | - |
Protego Biopharma, Inc.
 Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Protego Biopharma operates as a biotechnology firm. The company is headquartered in San Diego, CA. | Founder | 01-01-2017 |
Eerdere bekende functies van Jeffery Kelly
| Bedrijven | Functie | Einde |
|---|---|---|
| YUMANITY THERAPEUTICS | Founder | - |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Founder | - |
Yumanity Holdings LLC
 Yumanity Holdings LLC Medical/Nursing ServicesHealth Services Yumanity Holdings LLC provides healthcare services. The company was founded in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Founder | - |
Opleiding van Jeffery Kelly
| The University of North Carolina at Asheville | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
Yumanity Holdings LLC
Yumanity Holdings LLC Medical/Nursing ServicesHealth Services Yumanity Holdings LLC provides healthcare services. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Services |
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Protego Biopharma operates as a biotechnology firm. The company is headquartered in San Diego, CA. | Commercial Services |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
| The George E Hewitt Foundation For Medical Research |
